It has been reported that some bulbar onset MG with positive anti-AChR or anti-MuSK antibodies can mimic ALS (23, 35–37), so experimental immune-modulating therapy is necessary when it is too difficult to differentiate MG from ALS. This evidence concerns the gene MUSK and myasthenia gravis.